评估窦性心律伴有左心房阑尾不活动的严重风湿性二尖瓣狭窄患者的凝血因子

IF 2.5 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS CJC Open Pub Date : 2024-10-01 DOI:10.1016/j.cjco.2024.07.004
Saibal Mukhopadhyay DM , Narendra Kumar Chauhan DM , Ghazi Muheeb DM , Jamal Yusuf DM , Vimal Mehta DM , Bhawna Mahajan MD , Sanjeev Kathuria DM , Rupesh Santosh Agrawal DM
{"title":"评估窦性心律伴有左心房阑尾不活动的严重风湿性二尖瓣狭窄患者的凝血因子","authors":"Saibal Mukhopadhyay DM ,&nbsp;Narendra Kumar Chauhan DM ,&nbsp;Ghazi Muheeb DM ,&nbsp;Jamal Yusuf DM ,&nbsp;Vimal Mehta DM ,&nbsp;Bhawna Mahajan MD ,&nbsp;Sanjeev Kathuria DM ,&nbsp;Rupesh Santosh Agrawal DM","doi":"10.1016/j.cjco.2024.07.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Patients with severe mitral stenosis (MS) in normal sinus rhythm (NSR), presenting with left atrial appendage (LAA) inactivity and associated left atrial spontaneous echo contrast (LASEC) are prone to left atrium (LA) or LAA thrombus formation. But unlike for atrial fibrillation, oral anticoagulants are not commonly prescribed for this patient subset. This study aimed to compare the levels of procoagulants and fibrinogen in both local (LA) and systemic contexts between patients with severe MS in NSR vs those in healthy control subjects.</div></div><div><h3>Methods</h3><div>The study involved 35 patients with severe MS in NSR with LAA inactivity and LASEC who were eligible for balloon mitral valvuloplasty vs 35 healthy controls. All patients underwent transthoracic and transesophageal echocardiography to assess MS severity, LAA activity, and LASEC grade, and had blood samples analyzed for procoagulant levels.</div></div><div><h3>Results</h3><div>Results showed comparable baseline characteristics between groups, with most patients in the New York Heart Association II or III functional classes, and with varying LASEC grades. Patients exhibited significantly higher levels of prothrombin fragment 1 + 2 [patient vs control, 9017 pg/mL (6228.0-10,963.5) vs 1790 pg/mL (842.3-2712), <em>P</em> &lt; 0.0001], thrombin-antithrombin III [patient vs control, 39 ng/mL (5.45-74.85) vs 2.80 ng/mL (1.6-6.5), <em>P</em> &lt; 0.0001], plasminogen activator inhibitor-1 (patients vs controls, 26.09 ± 8.18 ng/mL vs 8.05 ± 3.53 ng/mL, <em>P</em> &lt; 0.0001), and fibrinogen (3.48 ± 0.89 g/L vs 3.01 ± 0.53 g/L, <em>P</em> = 0.029) in the LA of patients, compared to those in control subjects. Systemic procoagulant levels also were elevated in patients, but D-dimer levels were similar between the 2 groups.</div></div><div><h3>Conclusions</h3><div>The findings suggest a hypercoagulable state in patients, similar to that in patients with atrial fibrillation. The study advocates for consideration of use of oral anticoagulants in these patients until LA and LAA function improves, to mitigate thrombus formation.</div></div>","PeriodicalId":36924,"journal":{"name":"CJC Open","volume":"6 10","pages":"Pages 1231-1239"},"PeriodicalIF":2.5000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Assessment of Coagulation Factors in Patients with Severe Rheumatic Mitral Stenosis in Sinus Rhythm with Left Atrial Appendage Inactivity\",\"authors\":\"Saibal Mukhopadhyay DM ,&nbsp;Narendra Kumar Chauhan DM ,&nbsp;Ghazi Muheeb DM ,&nbsp;Jamal Yusuf DM ,&nbsp;Vimal Mehta DM ,&nbsp;Bhawna Mahajan MD ,&nbsp;Sanjeev Kathuria DM ,&nbsp;Rupesh Santosh Agrawal DM\",\"doi\":\"10.1016/j.cjco.2024.07.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Patients with severe mitral stenosis (MS) in normal sinus rhythm (NSR), presenting with left atrial appendage (LAA) inactivity and associated left atrial spontaneous echo contrast (LASEC) are prone to left atrium (LA) or LAA thrombus formation. But unlike for atrial fibrillation, oral anticoagulants are not commonly prescribed for this patient subset. This study aimed to compare the levels of procoagulants and fibrinogen in both local (LA) and systemic contexts between patients with severe MS in NSR vs those in healthy control subjects.</div></div><div><h3>Methods</h3><div>The study involved 35 patients with severe MS in NSR with LAA inactivity and LASEC who were eligible for balloon mitral valvuloplasty vs 35 healthy controls. All patients underwent transthoracic and transesophageal echocardiography to assess MS severity, LAA activity, and LASEC grade, and had blood samples analyzed for procoagulant levels.</div></div><div><h3>Results</h3><div>Results showed comparable baseline characteristics between groups, with most patients in the New York Heart Association II or III functional classes, and with varying LASEC grades. Patients exhibited significantly higher levels of prothrombin fragment 1 + 2 [patient vs control, 9017 pg/mL (6228.0-10,963.5) vs 1790 pg/mL (842.3-2712), <em>P</em> &lt; 0.0001], thrombin-antithrombin III [patient vs control, 39 ng/mL (5.45-74.85) vs 2.80 ng/mL (1.6-6.5), <em>P</em> &lt; 0.0001], plasminogen activator inhibitor-1 (patients vs controls, 26.09 ± 8.18 ng/mL vs 8.05 ± 3.53 ng/mL, <em>P</em> &lt; 0.0001), and fibrinogen (3.48 ± 0.89 g/L vs 3.01 ± 0.53 g/L, <em>P</em> = 0.029) in the LA of patients, compared to those in control subjects. Systemic procoagulant levels also were elevated in patients, but D-dimer levels were similar between the 2 groups.</div></div><div><h3>Conclusions</h3><div>The findings suggest a hypercoagulable state in patients, similar to that in patients with atrial fibrillation. The study advocates for consideration of use of oral anticoagulants in these patients until LA and LAA function improves, to mitigate thrombus formation.</div></div>\",\"PeriodicalId\":36924,\"journal\":{\"name\":\"CJC Open\",\"volume\":\"6 10\",\"pages\":\"Pages 1231-1239\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CJC Open\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2589790X2400283X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CJC Open","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2589790X2400283X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

背景在正常窦性心律(NSR)下患有严重二尖瓣狭窄(MS)、左心房附壁(LAA)不活动并伴有左心房自发回声对比(LASEC)的患者很容易形成左心房(LA)或 LAA 血栓。但与心房颤动不同的是,口服抗凝药并不常用于这类患者。本研究旨在比较 NSR 重度 MS 患者与健康对照组患者在局部(LA)和全身范围内的促凝血剂和纤维蛋白原水平。所有患者均接受了经胸和经食道超声心动图检查,以评估 MS 的严重程度、LAA 活动性和 LASEC 分级,并对血液样本进行了促凝血剂水平分析。结果结果显示,各组患者的基线特征相当,大多数患者属于纽约心脏协会 II 或 III 功能分级,LASEC 分级各不相同。患者的凝血酶原片段 1 + 2 [患者 vs 对照组,9017 pg/mL (6228.0-10,963.5) vs 1790 pg/mL (842.3-2712),P < 0.0001]、凝血酶原-抗凝血酶 III [患者 vs 对照组,39 ng/mL (5.45-74.85) vs 2.80 ng/mL (1.6-6. 5),P < 0.0001]、凝血酶原-抗凝血酶 III 水平明显更高。与对照组相比,患者 LA 中的凝血酶原-抗凝血酶 III [患者 vs 对照组,39 ng/mL (5.45-74.85) vs 2.80 ng/mL (1.6-6.5), P < 0.0001]、纤溶酶原激活物抑制剂-1(患者 vs 对照组,26.09 ± 8.18 ng/mL vs 8.05 ± 3.53 ng/mL,P < 0.0001)和纤维蛋白原(3.48 ± 0.89 g/L vs 3.01 ± 0.53 g/L,P = 0.029)。患者的全身促凝血剂水平也有所升高,但两组患者的 D-二聚体水平相似。该研究主张考虑对这些患者使用口服抗凝剂,直到 LA 和 LAA 功能改善,以减少血栓形成。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Assessment of Coagulation Factors in Patients with Severe Rheumatic Mitral Stenosis in Sinus Rhythm with Left Atrial Appendage Inactivity

Background

Patients with severe mitral stenosis (MS) in normal sinus rhythm (NSR), presenting with left atrial appendage (LAA) inactivity and associated left atrial spontaneous echo contrast (LASEC) are prone to left atrium (LA) or LAA thrombus formation. But unlike for atrial fibrillation, oral anticoagulants are not commonly prescribed for this patient subset. This study aimed to compare the levels of procoagulants and fibrinogen in both local (LA) and systemic contexts between patients with severe MS in NSR vs those in healthy control subjects.

Methods

The study involved 35 patients with severe MS in NSR with LAA inactivity and LASEC who were eligible for balloon mitral valvuloplasty vs 35 healthy controls. All patients underwent transthoracic and transesophageal echocardiography to assess MS severity, LAA activity, and LASEC grade, and had blood samples analyzed for procoagulant levels.

Results

Results showed comparable baseline characteristics between groups, with most patients in the New York Heart Association II or III functional classes, and with varying LASEC grades. Patients exhibited significantly higher levels of prothrombin fragment 1 + 2 [patient vs control, 9017 pg/mL (6228.0-10,963.5) vs 1790 pg/mL (842.3-2712), P < 0.0001], thrombin-antithrombin III [patient vs control, 39 ng/mL (5.45-74.85) vs 2.80 ng/mL (1.6-6.5), P < 0.0001], plasminogen activator inhibitor-1 (patients vs controls, 26.09 ± 8.18 ng/mL vs 8.05 ± 3.53 ng/mL, P < 0.0001), and fibrinogen (3.48 ± 0.89 g/L vs 3.01 ± 0.53 g/L, P = 0.029) in the LA of patients, compared to those in control subjects. Systemic procoagulant levels also were elevated in patients, but D-dimer levels were similar between the 2 groups.

Conclusions

The findings suggest a hypercoagulable state in patients, similar to that in patients with atrial fibrillation. The study advocates for consideration of use of oral anticoagulants in these patients until LA and LAA function improves, to mitigate thrombus formation.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CJC Open
CJC Open Medicine-Cardiology and Cardiovascular Medicine
CiteScore
3.30
自引率
0.00%
发文量
143
审稿时长
60 days
期刊最新文献
Cardiac Papillary Fibroelastoma and Cerebrovascular Events: A Systematic Review Late-Onset Mitral Valve Prosthesis Dehiscence With Severe Paravalvular Leak—Infectious Versus Noninfectious Etiology Dilemma: A Case Report Assessing the Safety of Early Repatriation for Stable ST-Segment Elevation Myocardial Infarction Patients After Primary Percutaneous Coronary Intervention Coronary Sinus Reducer Improves Myocardial Perfusion in a Patient With Angina, Hypertrophic Cardiomyopathy, and Coronary Microvascular Disease Fractured and Entrapped Coronary Angioplasty Balloon Successfully Managed with Rotational Atherectomy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1